Business Breakfast with Sarah Fredriksson, CEO of Aqilion

Meet Sarah Fredriksson, CEO of Aqilion

We’re pleased to welcome Sarah Fredriksson as she will give us a personal take on the topic – Who would like to be a biotech entrepreneur? During this presentation, Sarah will try to answer that question from a personal perspective. You will learn about the early days of her journey when she left the University to become CEO and founder of the startup Genovis. She will continue with her experiences and reflections as a serial entrepreneur, now serving as CEO of Aqilion. Sarah will touch upon science and data as well as funding, IPOs, leadership, business development, and why the unexpected is sometimes beautiful. How it works 7:50 – Breakfast is served. 8:10 – Welcome by KI Science Park 8:15 – 8:40 Presentation by invited guest 8:40 – 9:00 Q&A and discussion 9:00 – 9:15 Netwoking Who is Sarah Fredriksson? Sarah Fredriksson is a scientist turned entrepreneur. Her main inspiration and motivation come from new knowledge and science that could potentially change the future for people suffering from diseases that currently lack effective treatments. She founded Genovis AB right after completing her PhD in biochemistry at Lund University. Over more than 15 years as CEO, she was part of a young, dedicated team that developed and launched products on a global market, including through subsidiaries in the US. The company was listed/introduced on First North, Nasdaq OMX Nordic, at the same time. Sarah has many years of experience in leadership and product development within smaller, innovative biotech companies. For several years, she’s been active as an entrepreneur, CEO, and board member of both private and public life science companies. She has also served on the board of Lund University, Lund University School of Engineering (LTH), and the industry organization SwedenBIO. Additionally, she is active as a mentor at the Termeer Institute in the US. About Aqilion Aqilion is a Swedish biopharma company that develops innovative new therapies for diseases caused by chronic inflammation and dysfunctional immune reactions. The company is mainly active in the idea stage to early clinical development. The goal is to demonstrate the clinical and commercial potential of the medical innovation to attract industrial partners and buyers, who in turn have the capacity to continue clinical development and take the drug to the patients. Aqilion runs its development programs in a partly virtual organization in close collaboration with selected partners with specific expertise in drug development. REGISTRATION Members receive early access through a personal invitation. One week before the event, registration will open here on the website for external participants. Warm welcome! _____________________________ About Business Breakfast Business Breakfast is KI Science Park’s monthly morning meet-up where business leaders share experiences, lessons, and inspiration. It’s a chance to reconnect, broaden your network, and kick off the day with fresh energy and new ideas. The event is arranged in collaboration with A Working Lab at Innomedicum.